Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

[Pharmaceutical policy and health economics].

Kakihara H, Ibuka Y, Ma X.

Nihon Yakurigaku Zasshi. 2013 Feb;141(2):95-9. Japanese. No abstract available.

PMID:
23391550
2.

[8th Descartes-Berkeley interuniversity symposium on health economics, May 2013, Paris, France: an overview].

Lhoste F.

Ann Pharm Fr. 2013 Sep;71(5):277-8. doi: 10.1016/j.pharma.2013.08.001. Epub 2013 Sep 5. French. No abstract available.

PMID:
24075697
3.

[Healthy pharmaceutical policy].

González Pier E.

Salud Publica Mex. 2008;50 Suppl 4:S488-95. Review. Spanish.

4.

The physician and cost.

Nash DB.

J Pharm Mark Manage. 1987 Winter;2(2):49-58. No abstract available.

PMID:
10287954
5.
6.

The practitioner, the patient, the resident, and the pharmaceutical "gift".

Harlass FE, Uharriet P, Sakakini J Jr.

Mil Med. 1995 Sep;160(9):A10. No abstract available.

PMID:
7478023
7.

Domestic pharmaceutical production in 1999 reaches yen 6.29 trillion.

[No authors listed]

Front Med Biol Eng. 2001;11(2):153. No abstract available.

PMID:
11575465
8.

[Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].

Persson U, Ramsberg J.

Lakartidningen. 2007 Oct 17-23;104(42):3046-50. Swedish. No abstract available.

PMID:
17985712
9.

New economics of the pharmaceutical supply chain.

Yost RD.

Am J Health Syst Pharm. 2005 Mar 1;62(5):525-6. No abstract available.

PMID:
15745917
10.

Biotechnology's metamorphosis into a drug discovery industry.

Drews J.

Nat Biotechnol. 1998 May;16 Suppl:22-4. No abstract available.

PMID:
9591258
11.

Comment on "The economics of follow-on drug research and development: trends in entry rates and the timing of development".

Hollis A.

Pharmacoeconomics. 2005;23(12):1187-92; discussion 1193-202. No abstract available.

PMID:
16336012
14.

Medicine, pharmacy, and industry--a fly's eye view of health care.

Halperin JA.

Ann Pharmacother. 1995 Sep;29(9):925-33. No abstract available.

PMID:
8547743
15.

[Future of the medical engineering industry].

Iwai Y.

Iyodenshi To Seitai Kogaku. 1982 Dec;20(7):606-8. Japanese. No abstract available.

PMID:
7186988
16.

The future research agenda. A view from the pharmaceutical industry.

Barr C.

Pharmacoeconomics. 1994;6 Suppl 1:61-2.

PMID:
10155587
17.

A modern pharmaceutical company.

Erle HR.

Clin Pharmacol Ther. 2002 Jan;71(1):103-4. No abstract available.

PMID:
11823763
18.

Health economics and health economics research.

Klarman HE.

Milbank Mem Fund Q Health Soc. 1979 Summer;57(3):371-9. No abstract available.

PMID:
112491
19.

The future of health economics.

Fuchs VR.

J Health Econ. 2000 Mar;19(2):141-57. Review.

PMID:
10947574
20.

The quiet revolution: outsourcing in pharma.

Crossley R.

Drug Discov Today. 2004 Aug 15;9(16):694. No abstract available.

PMID:
15341780
Items per page

Supplemental Content

Write to the Help Desk